Global NGS-based RNA-sequencing Market Research Report 2026(Status and Outlook)
Description
Report Overview
Gene expression studies can also involve looking at profiles or patterns of expression of several genes. RNA sequencing (RNA-Seq) leverages the advantages of next-generation sequencing (NGS) to detect and quantify RNA in a biological sample at a given point in time.A significant driver in the NGS-based RNA-sequencing market is the increasing demand for comprehensive and high-throughput analysis of RNA molecules for research and clinical applications. Next-generation sequencing (NGS) technology enables researchers to examine gene expression, identify alternative splicing events, and detect RNA modifications at an unprecedented scale. However, a notable challenge in this market is the need for data analysis and storage solutions. Managing the vast amount of data generated by NGS-based RNA-sequencing while ensuring data accuracy, security, and accessibility poses a significant challenge. Bioinformatics tools, cloud-based solutions, and data management strategies must be continually developed to streamline data analysis and storage processes, facilitating the broader adoption of NGS-based RNA-sequencing in genomics research and precision medicine.
The global NGS-based RNA-sequencing market size was estimated at USD 3470.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 17.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global NGS-based RNA-sequencing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global NGS-based RNA-sequencing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the NGS-based RNA-sequencing market.
Global NGS-based RNA-sequencing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Illumina
Thermo Fischer Scientific
Oxford Nanopore
Agilent Technologies
BGI
PerkinElmer
QIAGEN
Eurofins Scientific
Roche
Takara Bio
GENEWIZ
Hamilton
Macrogen
Zymo Research
Tecan Genomics
Market Segmentation (by Type)
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
Market Segmentation (by Application)
Research & Academia
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the NGS-based RNA-sequencing Market
Overview of the regional outlook of the NGS-based RNA-sequencing Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the NGS-based RNA-sequencing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of NGS-based RNA-sequencing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Gene expression studies can also involve looking at profiles or patterns of expression of several genes. RNA sequencing (RNA-Seq) leverages the advantages of next-generation sequencing (NGS) to detect and quantify RNA in a biological sample at a given point in time.A significant driver in the NGS-based RNA-sequencing market is the increasing demand for comprehensive and high-throughput analysis of RNA molecules for research and clinical applications. Next-generation sequencing (NGS) technology enables researchers to examine gene expression, identify alternative splicing events, and detect RNA modifications at an unprecedented scale. However, a notable challenge in this market is the need for data analysis and storage solutions. Managing the vast amount of data generated by NGS-based RNA-sequencing while ensuring data accuracy, security, and accessibility poses a significant challenge. Bioinformatics tools, cloud-based solutions, and data management strategies must be continually developed to streamline data analysis and storage processes, facilitating the broader adoption of NGS-based RNA-sequencing in genomics research and precision medicine.
The global NGS-based RNA-sequencing market size was estimated at USD 3470.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 17.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global NGS-based RNA-sequencing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global NGS-based RNA-sequencing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the NGS-based RNA-sequencing market.
Global NGS-based RNA-sequencing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Illumina
Thermo Fischer Scientific
Oxford Nanopore
Agilent Technologies
BGI
PerkinElmer
QIAGEN
Eurofins Scientific
Roche
Takara Bio
GENEWIZ
Hamilton
Macrogen
Zymo Research
Tecan Genomics
Market Segmentation (by Type)
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
Market Segmentation (by Application)
Research & Academia
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the NGS-based RNA-sequencing Market
Overview of the regional outlook of the NGS-based RNA-sequencing Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the NGS-based RNA-sequencing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of NGS-based RNA-sequencing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
154 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of NGS-based RNA-sequencing
- 1.2 Key Market Segments
- 1.2.1 NGS-based RNA-sequencing Segment by Type
- 1.2.2 NGS-based RNA-sequencing Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 NGS-based RNA-sequencing Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global NGS-based RNA-sequencing Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global NGS-based RNA-sequencing Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 NGS-based RNA-sequencing Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global NGS-based RNA-sequencing Product Life Cycle
- 3.3 Global NGS-based RNA-sequencing Sales by Manufacturers (2020-2025)
- 3.4 Global NGS-based RNA-sequencing Revenue Market Share by Manufacturers (2020-2025)
- 3.5 NGS-based RNA-sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global NGS-based RNA-sequencing Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 NGS-based RNA-sequencing Market Competitive Situation and Trends
- 3.8.1 NGS-based RNA-sequencing Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest NGS-based RNA-sequencing Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 NGS-based RNA-sequencing Industry Chain Analysis
- 4.1 NGS-based RNA-sequencing Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of NGS-based RNA-sequencing Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global NGS-based RNA-sequencing Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to NGS-based RNA-sequencing Market
- 5.7 ESG Ratings of Leading Companies
- 6 NGS-based RNA-sequencing Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global NGS-based RNA-sequencing Sales Market Share by Type (2020-2025)
- 6.3 Global NGS-based RNA-sequencing Market Size by Type (2020-2025)
- 6.4 Global NGS-based RNA-sequencing Price by Type (2020-2025)
- 7 NGS-based RNA-sequencing Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global NGS-based RNA-sequencing Market Sales by Application (2020-2025)
- 7.3 Global NGS-based RNA-sequencing Market Size (M USD) by Application (2020-2025)
- 7.4 Global NGS-based RNA-sequencing Sales Growth Rate by Application (2020-2025)
- 8 NGS-based RNA-sequencing Market Sales by Region
- 8.1 Global NGS-based RNA-sequencing Sales by Region
- 8.1.1 Global NGS-based RNA-sequencing Sales by Region
- 8.1.2 Global NGS-based RNA-sequencing Sales Market Share by Region
- 8.2 Global NGS-based RNA-sequencing Market Size by Region
- 8.2.1 Global NGS-based RNA-sequencing Market Size by Region
- 8.2.2 Global NGS-based RNA-sequencing Market Size by Region
- 8.3 North America
- 8.3.1 North America NGS-based RNA-sequencing Sales by Country
- 8.3.2 North America NGS-based RNA-sequencing Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe NGS-based RNA-sequencing Sales by Country
- 8.4.2 Europe NGS-based RNA-sequencing Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific NGS-based RNA-sequencing Sales by Region
- 8.5.2 Asia Pacific NGS-based RNA-sequencing Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America NGS-based RNA-sequencing Sales by Country
- 8.6.2 South America NGS-based RNA-sequencing Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa NGS-based RNA-sequencing Sales by Region
- 8.7.2 Middle East and Africa NGS-based RNA-sequencing Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 NGS-based RNA-sequencing Market Production by Region
- 9.1 Global Production of NGS-based RNA-sequencing by Region(2020-2025)
- 9.2 Global NGS-based RNA-sequencing Revenue Market Share by Region (2020-2025)
- 9.3 Global NGS-based RNA-sequencing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America NGS-based RNA-sequencing Production
- 9.4.1 North America NGS-based RNA-sequencing Production Growth Rate (2020-2025)
- 9.4.2 North America NGS-based RNA-sequencing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe NGS-based RNA-sequencing Production
- 9.5.1 Europe NGS-based RNA-sequencing Production Growth Rate (2020-2025)
- 9.5.2 Europe NGS-based RNA-sequencing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan NGS-based RNA-sequencing Production (2020-2025)
- 9.6.1 Japan NGS-based RNA-sequencing Production Growth Rate (2020-2025)
- 9.6.2 Japan NGS-based RNA-sequencing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China NGS-based RNA-sequencing Production (2020-2025)
- 9.7.1 China NGS-based RNA-sequencing Production Growth Rate (2020-2025)
- 9.7.2 China NGS-based RNA-sequencing Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Illumina
- 10.1.1 Illumina Basic Information
- 10.1.2 Illumina NGS-based RNA-sequencing Product Overview
- 10.1.3 Illumina NGS-based RNA-sequencing Product Market Performance
- 10.1.4 Illumina Business Overview
- 10.1.5 Illumina SWOT Analysis
- 10.1.6 Illumina Recent Developments
- 10.2 Thermo Fischer Scientific
- 10.2.1 Thermo Fischer Scientific Basic Information
- 10.2.2 Thermo Fischer Scientific NGS-based RNA-sequencing Product Overview
- 10.2.3 Thermo Fischer Scientific NGS-based RNA-sequencing Product Market Performance
- 10.2.4 Thermo Fischer Scientific Business Overview
- 10.2.5 Thermo Fischer Scientific SWOT Analysis
- 10.2.6 Thermo Fischer Scientific Recent Developments
- 10.3 Oxford Nanopore
- 10.3.1 Oxford Nanopore Basic Information
- 10.3.2 Oxford Nanopore NGS-based RNA-sequencing Product Overview
- 10.3.3 Oxford Nanopore NGS-based RNA-sequencing Product Market Performance
- 10.3.4 Oxford Nanopore Business Overview
- 10.3.5 Oxford Nanopore SWOT Analysis
- 10.3.6 Oxford Nanopore Recent Developments
- 10.4 Agilent Technologies
- 10.4.1 Agilent Technologies Basic Information
- 10.4.2 Agilent Technologies NGS-based RNA-sequencing Product Overview
- 10.4.3 Agilent Technologies NGS-based RNA-sequencing Product Market Performance
- 10.4.4 Agilent Technologies Business Overview
- 10.4.5 Agilent Technologies Recent Developments
- 10.5 BGI
- 10.5.1 BGI Basic Information
- 10.5.2 BGI NGS-based RNA-sequencing Product Overview
- 10.5.3 BGI NGS-based RNA-sequencing Product Market Performance
- 10.5.4 BGI Business Overview
- 10.5.5 BGI Recent Developments
- 10.6 PerkinElmer
- 10.6.1 PerkinElmer Basic Information
- 10.6.2 PerkinElmer NGS-based RNA-sequencing Product Overview
- 10.6.3 PerkinElmer NGS-based RNA-sequencing Product Market Performance
- 10.6.4 PerkinElmer Business Overview
- 10.6.5 PerkinElmer Recent Developments
- 10.7 QIAGEN
- 10.7.1 QIAGEN Basic Information
- 10.7.2 QIAGEN NGS-based RNA-sequencing Product Overview
- 10.7.3 QIAGEN NGS-based RNA-sequencing Product Market Performance
- 10.7.4 QIAGEN Business Overview
- 10.7.5 QIAGEN Recent Developments
- 10.8 Eurofins Scientific
- 10.8.1 Eurofins Scientific Basic Information
- 10.8.2 Eurofins Scientific NGS-based RNA-sequencing Product Overview
- 10.8.3 Eurofins Scientific NGS-based RNA-sequencing Product Market Performance
- 10.8.4 Eurofins Scientific Business Overview
- 10.8.5 Eurofins Scientific Recent Developments
- 10.9 Roche
- 10.9.1 Roche Basic Information
- 10.9.2 Roche NGS-based RNA-sequencing Product Overview
- 10.9.3 Roche NGS-based RNA-sequencing Product Market Performance
- 10.9.4 Roche Business Overview
- 10.9.5 Roche Recent Developments
- 10.10 Takara Bio
- 10.10.1 Takara Bio Basic Information
- 10.10.2 Takara Bio NGS-based RNA-sequencing Product Overview
- 10.10.3 Takara Bio NGS-based RNA-sequencing Product Market Performance
- 10.10.4 Takara Bio Business Overview
- 10.10.5 Takara Bio Recent Developments
- 10.11 GENEWIZ
- 10.11.1 GENEWIZ Basic Information
- 10.11.2 GENEWIZ NGS-based RNA-sequencing Product Overview
- 10.11.3 GENEWIZ NGS-based RNA-sequencing Product Market Performance
- 10.11.4 GENEWIZ Business Overview
- 10.11.5 GENEWIZ Recent Developments
- 10.12 Hamilton
- 10.12.1 Hamilton Basic Information
- 10.12.2 Hamilton NGS-based RNA-sequencing Product Overview
- 10.12.3 Hamilton NGS-based RNA-sequencing Product Market Performance
- 10.12.4 Hamilton Business Overview
- 10.12.5 Hamilton Recent Developments
- 10.13 Macrogen
- 10.13.1 Macrogen Basic Information
- 10.13.2 Macrogen NGS-based RNA-sequencing Product Overview
- 10.13.3 Macrogen NGS-based RNA-sequencing Product Market Performance
- 10.13.4 Macrogen Business Overview
- 10.13.5 Macrogen Recent Developments
- 10.14 Zymo Research
- 10.14.1 Zymo Research Basic Information
- 10.14.2 Zymo Research NGS-based RNA-sequencing Product Overview
- 10.14.3 Zymo Research NGS-based RNA-sequencing Product Market Performance
- 10.14.4 Zymo Research Business Overview
- 10.14.5 Zymo Research Recent Developments
- 10.15 Tecan Genomics
- 10.15.1 Tecan Genomics Basic Information
- 10.15.2 Tecan Genomics NGS-based RNA-sequencing Product Overview
- 10.15.3 Tecan Genomics NGS-based RNA-sequencing Product Market Performance
- 10.15.4 Tecan Genomics Business Overview
- 10.15.5 Tecan Genomics Recent Developments
- 11 NGS-based RNA-sequencing Market Forecast by Region
- 11.1 Global NGS-based RNA-sequencing Market Size Forecast
- 11.2 Global NGS-based RNA-sequencing Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe NGS-based RNA-sequencing Market Size Forecast by Country
- 11.2.3 Asia Pacific NGS-based RNA-sequencing Market Size Forecast by Region
- 11.2.4 South America NGS-based RNA-sequencing Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of NGS-based RNA-sequencing by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global NGS-based RNA-sequencing Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of NGS-based RNA-sequencing by Type (2026-2035)
- 12.1.2 Global NGS-based RNA-sequencing Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of NGS-based RNA-sequencing by Type (2026-2035)
- 12.2 Global NGS-based RNA-sequencing Market Forecast by Application (2026-2035)
- 12.2.1 Global NGS-based RNA-sequencing Sales (K Units) Forecast by Application
- 12.2.2 Global NGS-based RNA-sequencing Market Size (M USD) Forecast by Application (2026-2035)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
